Skip to main content
U.S. flag
Health and Human Services Logo

An official website of the Department of Health & Human Services

menu-iconMore mobile-close-icon
mobile-back-btn-icon Back
  • menu-iconMenu
  • mobile-search-icon
AHRQ: Agency for Healthcare Research and Quality
  • Search All AHRQ Sites
  • Careers
  • Contact Us
  • Español
  • FAQs
  • Email Updates
MEPS Home Medical Expenditure Panel Survey
Font Size:
Contact MEPS FAQ Site Map  
S
M
L
XL
spacer
 MEPS Home
 About MEPS
 :: Survey Background
 :: Workshops & Events
 :: Data Release Schedule
 Survey Components
 :: Household
 :: Insurance/Employer
 :: Medical Provider
 :: Survey Questionnaires
 Data and Statistics
 :: Data Overview
 :: MEPS Topics
 :: Publications Search
 :: MEPS Data Tools (HC/IC)
 :: Data Files
 :: Data Centers
 Communication
 :: What's New
 :: Mailing List
 :: Discussion Forum
 :: Participants' Corner
   
MEPS Topics: Prescribed Drug Use/Events and Expenditures
Click here for full topic list.

Visit the AHRQ Data Tools to explore AHRQ data resources to view and analyze statistics on all aspects of healthcare in the United States.

""
Prescribed Drug Use/Events and Expenditures
Description: Prescription drugs are a large portion of health care expenditures and are defined as those drugs which are ordered by a physician or other authorized medical personnel through written or verbal prescription for a pharmacist to fill for the patient. MEPS collects information from survey participants about their prescription drugs and then are asked for permission to collect more detailed information from their pharmacies. At the pharmacies, data are collected on the type, dosage, and payment for each filled prescription. No information is collected for over-the-counter medications. Prescribed drug expenditures in MEPS are defined as the sum of payments for care received, including out of pocket payments and payments made by private insurance, Medicaid, Medicare and other sources. The Prescribed Medicines Files are available as part of the event-level files. Information summarized to the person-level is available on the full-year consolidated files under the Household Full Year Files.
Publications: Publications are listed in reverse chronological order (most recent first).
Average Annual Total Expenses, Total Utilization, and Sources of Payment for Outpatient Prescription Opioids in the U.S. Adult Civilian Noninstitutionalized Population, 2021-2022 
Statistical Brief #559 
Any Use and "Frequent Use" of Opioids among Adults Aged 18-64 in 2020-2021, by Socioeconomic Characteristics 
Statistical Brief #552 
Any Use and "Frequent Use" of Opioids among Adults Aged 65 and Older in 2020-2021, by Socioeconomic Characteristics 
Statistical Brief #551 
Evaluating Alternative Benchmarks to Improve Identification of Outlier Drug Prices for Medical Expenditure Panel Survey Prescribed Medicines Data Editing 
Working Paper #22001 
Any Use and "Frequent Use" of Opioids among Non-Elderly Adults in 2018-2019, by Socioeconomic Characteristics 
Statistical Brief #542 
Any Use and "Frequent Use" of Opioids among Elderly Adults in 2018-2019, by Socioeconomic Characteristics 
Statistical Brief #541 
Average Expenditures per Prescription Antidepressant Fill in the U.S. Civilian Noninstitutionalized Population by Select Sociodemographic Characteristics, 2013 and 2018 
Statistical Brief #538 
Pre-COVID-19 Retail Use and Expenditures for Drugs That Were Subsequently Used to Treat COVID-19 
Research Findings #49 
Comparison of the Total Number of People in the U.S. Civilian Noninstitutionalized Population Purchasing One or More Antidepressant or Antipsychotic Prescriptions by Select Sociodemographic Characteristics, 2013 and 2018 
Statistical Brief #535 
Comparison of Antidepressant and Antipsychotic Utilization and Expenditures in the U.S. Civilian Noninstitutionalized Population, 2013 and 2018 
Statistical Brief #534 
Out-of-Pocket Spending for Retail Prescribed Drugs by Age and Type of Prescription Drug Coverage, 2009 to 2018 
Statistical Brief #532 
Total Expenses, Total Utilization, and Sources of Payment for Outpatient Prescription Opioids in the U.S. Adult Civilian Noninstitutionalized Population, 2017 
Statistical Brief #529 
Trends in Prescribed Medication Expenditures by Age and Type of Prescription Drug Coverage, 2009 to 2016 MEPS-HC 
Statistical Brief #522 
Any Use and Frequent Use of Opioids among Non-Elderly Adults in 2015-2016, by Socioeconomic Characteristics 
Statistical Brief #516 
Any Use and Frequent Use of Opioids among Elderly Adults in 2015-2016, by Socioeconomic Characteristics 
Statistical Brief #515 
Total Expenses, Total Utilization, and Sources of Payment for Outpatient Prescription Opioids in the U.S. Adult Civilian Noninstitutionalized Population, 2015 
Statistical Brief #505 
Expenditures for Commonly Treated Conditions among Adults Age 18 and Older in the U.S. Civilian Noninstitutionalized Population, 2013 
Statistical Brief #487 
Trends in Prescribed Outpatient Opioid Use and Expenses in the U.S. Civilian Noninstitutionalized Population, 2002-2012 
Statistical Brief #478 
Top Five Most Costly Conditions among Children, Ages 0-17, 2012: Estimates for the U.S. Civilian Noninstitutionalized Population 
Statistical Brief #472 
Top Five Most Costly Conditions among Adults Age 18 and Older, 2012: Estimates for the U.S. Civilian Noninstitutionalized Population 
Statistical Brief #471 
1 to 20 of 76   >>Next>>
 
   Page last revised:  January 27, 2023
MEPS HOME . CONTACT MEPS . MEPS FAQ . MEPS SITE MAP . MEPS PRIVACY POLICY . ACCESSIBILITY . COPYRIGHT
Back to topGo back to top
Back to Top Go back to top

Connect With Us

Facebook Twitter You Tube LinkedIn

Sign up for Email Updates

To sign up for updates or to access your subscriber preferences, please enter your email address below.

Agency for Healthcare Research and Quality

5600 Fishers Lane
Rockville, MD 20857
Telephone: (301) 427-1364

  • Careers
  • Contact Us
  • Español
  • FAQs
  • Accessibility
  • Disclaimers
  • EEO
  • Electronic Policies
  • FOIA
  • HHS Digital Strategy
  • HHS Nondiscrimination Notice
  • Inspector General
  • Plain Writing Act
  • Privacy Policy
  • Viewers & Players
  • U.S. Department of Health & Human Services
  • The White House
  • USA.gov